GlassScriptPhysician profile
Alvin Marcovici
NPI 1376530337
$8,156.88
in general payments reported to CMS, 2019-2025
12 companies · $48.60 in 2025
The $48.60 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.29 · 2020: $5,327 · 2021: $30.05 · 2022: $242 · 2023: $2,313 · 2024: $103 · 2025: $48.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,462 · Travel and Lodging: $781 · Food and Beverage: $221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,462.14 |
| Travel and Lodging | $781.20 |
| Food and Beverage | $221.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Products, INC. | $6,823.95 | 2020-2023 | |
| Globus Medical, INC. | $770.78 | 2023 | Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System |
| Stryker Corporation | $192.74 | 2022-2023 | Spinejack |
| Depuy Synthes Sales INC. | $164.89 | 2019-2022 | |
| Nevro Corp. | $38.83 | 2024 | Senza |
| Medtronic, INC. | $34.73 | 2024 | Strata |
| Abbvie INC. | $29.83 | 2024 | |
| Orthofix Medical, INC. | $26.24 | 2021-2025 | Spinal-Stim |
| Argenx US, INC. | $22.48 | 2023 | Vyvgart |
| Abbott Laboratories | $21.28 | 2025 | Proclaim |
| Tonix Medicines, INC. | $18.50 | 2025 | Tonmya |
| Misonix INC | $12.63 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alvin Marcovici listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.